PDCD1 and hepatocellular carcinoma: HCC develops within an immune-tolerant niche, as the liver has multiple distinct mechanisms to suppress unwanted immune activation from bypassing antigen and bacteria channeled through the portal vein system, including the upregulation of immune checkpoints such as the programmed death-1 (PD-1) pathway [2,3].